Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1403746 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL29941787 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| Tetraethylene Glycol SCHEMBL23524451 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL14948191 | 1.00 | MEN1 (0.69) | MEN1KMT2ATSHRMAPK1THRB | |
| SCHEMBL61549 | 0.97 | — | — | |
| Di(Hydroxyethyl)Ether SCHEMBL1859973 | 0.97 | TSHR (0.67) | MEN1KMT2ATSHRMAPK1THRB | |
| Di(Hydroxyethyl)Ether SCHEMBL23524458 | 0.97 | TSHR (0.67) | MEN1KMT2ATSHRMAPK1THRB | |
| Ammonia Solution, Strong SCHEMBL28254082 | 0.94 | — | — | |
| SCHEMBL28142567 | 0.94 | — | — | |
| Tetraethylene Glycol SCHEMBL28289692 | 0.90 | MEN1 (0.73) | MEN1KMT2ATSHRMAPK1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | claimed |
| US-12455256-B2 | Immobilization strategies for enhancing sensitivity of electrochemical aptamer-based sensors | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-10-28 | — | — | US | claimed |
| US-12215039-B2 | Synthesis, capping, and dispersion of TiO2 nanocrystals | PT SPE SUBCO LLC (US) | 2025-02-04 | — | — | US | claimed |
| CN-117916299-A | Zirconia and titania formulations and nanocomposites for nanoimprint lithography | PT SPE塞博康有限责任公司 | 2024-04-19 | — | — | CN | claimed |
| US-20240053291-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2024-02-15 | — | — | US | claimed |
| US-20230213471-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2023-07-06 | — | — | US | claimed |
| CN-113227463-A | Synthesis, capping and dispersion of TiO2 nanocrystals | 皮瑟莱根特科技有限责任公司 | 2021-08-06 | — | — | CN | claimed |
| EP-2018559-A1 | FUNCTIONALIZATION OF GOLD NANOPARTICLES WITH ORIENTED PROTEINS. APPLICATION TO THE HIGH-DENSITY LABELLING OF CELL MEMBRANES | Centre National de la Recherche Scientifique (CNRS) (FR) | 2009-01-28 | — | — | EP | claimed |
| WO-2007122259-A1 | FUNCTIONALIZATION OF GOLD NANOPARTICLES WITH ORIENTED PROTEINS. APPLICATION TO THE HIGH-DENSITY LABELLING OF CELL MEMBRANES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2007-11-01 | — | — | WO | claimed |
| EP-4741406-A1 | NEUROKININ-1 RECEPTOR ANTAGONIST COMPOUND | Creadev (Nanjing) Pharmaceutical Technology Co., Ltd. (CN) | 2026-05-13 | — | — | EP | disclosed |
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2026-03-26 | — | — | US | disclosed |
| US-12455256-B2 | Immobilization strategies for enhancing sensitivity of electrochemical aptamer-based sensors | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2025-10-28 | — | — | US | disclosed |
| US-20250325644-A1 | ALK POLYPEPTIDES AND METHODS OF USE THEREOF | ELICIO THERAPEUTICS INC (US) | 2025-10-23 | — | — | US | disclosed |
| US-12370245-B2 | ALK polypeptides and methods of use thereof | Elicio Therapeutics, Inc. (US) | 2025-07-29 | — | — | US | disclosed |
| EP-0455705-A4 | RECEPTOR MEMBRANES AND IONOPHORE GATING | AU MEMBRANE & BIOTECH RES INST (AU) | 1992-09-16 | — | — | EP | disclosed |
| EP-0455705-A1 | RECEPTOR MEMBRANES AND IONOPHORE GATING. | AU MEMBRANE & BIOTECH RES INST (AU) | 1991-11-13 | — | — | EP | disclosed |
| WO-1990008783-A1 | RECEPTOR MEMBRANES AND IONOPHORE GATING | AUSTRALIAN MEMBRANE AND BIOTECHNOLOGY RESEARCH INSTITUTE (AU) | 1990-08-09 | — | — | WO | disclosed |
| US-4477614-A | FOR POLYAMIDES | CIBA-GEIGY CORPORATION (US) | 1984-10-16 | — | — | US | disclosed |
| US-4307034-A | ALKYLATION | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1981-12-22 | — | — | US | disclosed |
| US-4283327-A | USED AS A LIGHT STABILIZER | CIBA-GEIGY CORPORATION (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260086062-A1 | IMMOBILIZATION STRATEGIES FOR ENHANCING SENSITIVITY OF ELECTROCHEMICAL APTAMER-BASED SENSORS | EBPL, ADA, XBP1 | MEN1 4684/4885KMT2A 1012/4885TSHR 667/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.